Experimental Acute Pancreatitis
- 1 December 1979
- journal article
- research article
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 190 (6) , 728-731
- https://doi.org/10.1097/00000658-197912000-00009
Abstract
A canine model was devised to measure the O2 consumption of the pancreas in experimentally induced pancreatitis. Over the 120 min investigation period the O2 consumption fell by 63% in the presence of a diminishing pancreatic blood flow and constant arteriovenous percentage saturation across the pancreas. Dextran 40 had been previously shown to maintain the pancreatic circulation. Accordingly, a 2nd group of dogs was treated with Dextran 40 (1.5 ml/kg) 60 min after induction of the pancreatitis. This produced a significant increase in the pancreatic O2 consumption and widening of the arteriovenous difference. Dextran 40 appears to reverse the hypoxia of the pancreas noted in acute experimental pancreatitis.This publication has 28 references indexed in Scilit:
- Experimental pancreatitis: Effect of plasma and dextran on pancreatic blood flow.1978
- Pancreatic Acinar Cell Metabolism and FunctionGastroenterology, 1977
- Haematological abnormalities in acute pancreatitis. A prospective studyPublished by Oxford University Press (OUP) ,1977
- Low-Molecular-Weight Dextran Therapy in Experimental PancreatitisJAMA, 1965
- Central-Nervous-System Influence on Experimentally Induced PancreatitisJAMA, 1965
- Experimental PancreatitisAnnals of Surgery, 1963
- Rheomacrodex--a new dextran solution for rheological treatment of impaired capillary flow.1961
- POTENTIATING INFLUENCE OF APNEA, HYPOXIA, AND HYPERCAPNIA ON BILE-INDUCED HEMORRHAGIC PANCREATIC NECROSIS1960
- The use of human serum albumin in the management of acute pancreatitis; experimental and clinical observations.1955
- Acute hemorrhagic pancreatitis; report of 11 consecutive cases treated with human serum albumin.1953